 | • レポートコード：MRC2102QY12888 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の二次抗体市場について種類別（人間用、動物用）、用途別（ELISA（多くのHIV検査を含む）、ウエスタンブロット、免疫染色、免疫組織化学、免疫細胞化学）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・二次抗体市場の概要 ・世界の主要地域別二次抗体市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の二次抗体市場規模2015-2026：種類別（人間用、動物用） ・世界の二次抗体市場規模2015-2026：用途別（ELISA（多くのHIV検査を含む）、ウエスタンブロット、免疫染色、免疫組織化学、免疫細胞化学） ・二次抗体の米国市場規模2015-2020 ・二次抗体のヨーロッパ市場規模2015-2020 ・二次抗体の中国市場規模2015-2020 ・二次抗体の日本市場規模2015-2020 ・二次抗体の東南アジア市場規模2015-2020 ・二次抗体のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・二次抗体の製造コスト分析 ・販売チャネル、流通業者、顧客 ・二次抗体の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Secondary Antibodies Market
The global Secondary Antibodies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Secondary Antibodies Scope and Market Size
The global Secondary Antibodies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Secondary Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Secondary Antibodies market is segmented into
Men’
Animals’
Segment by Application, the Secondary Antibodies market is segmented into
ELISA (Including Many HIV Tests)
Western Blot
Immunostaining
Immunohistochemistry
Immunocytochemistry
The Secondary Antibodies market is analysed and market size information is provided by regions (countries). Segment by Application, the Secondary Antibodies market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Secondary Antibodies Market Share Analysis
Secondary Antibodies market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Secondary Antibodies business, the date to enter into the Secondary Antibodies market, Secondary Antibodies product introduction, recent developments, etc.
The major vendors covered:
Thermo Fisher Scientific (US)
Jackson ImmunoResearch Laboratories (US)
BD Biosciences (US)
Santa Cruz Biotechnology (US)
GE Healthcare (US)
Sigma-Aldrich (US)
Dako (US)
LI-COR Biosciences (US)
SouthernBiotech (US)
Vector Laboratories (US)
Bio-Rad (US)
eBioscience (US)
Cell Signaling Technology (US)
Dianova (Germany)
Abcam (UK)
EMD Millipore (US)
R&D Systems (US)
Rockland Immunochemicals (US)
Bethyl (US)
Kirkegaard & Perry Laboratories (US)
BioLegend (US)
Abbexa (UK)
Biorbyt (UK)
Acris Antibodies (Germany)
BioLogo (Germany)
Sino Biological (China)
1 Secondary Antibodies Market Overview
1.1 Secondary Antibodies Product Scope
1.2 Secondary Antibodies Segment by Type
1.2.1 Global Secondary Antibodies Sales by Type (2020-2026)
1.2.2 Men’
1.2.3 Animals’
1.3 Secondary Antibodies Segment by Application
1.3.1 Global Secondary Antibodies Sales Comparison by Application (2020-2026)
1.3.2 ELISA (Including Many HIV Tests)
1.3.3 Western Blot
1.3.4 Immunostaining
1.3.5 Immunohistochemistry
1.3.6 Immunocytochemistry
1.4 Secondary Antibodies Market Estimates and Forecasts (2015-2026)
1.4.1 Global Secondary Antibodies Sales Growth Rate (2015-2026)
1.4.2 Global Secondary Antibodies Revenue and Growth Rate (2015-2026)
1.4.3 Global Secondary Antibodies Price Trends (2015-2026)
2 Secondary Antibodies Estimate and Forecast by Region
2.1 Global Secondary Antibodies Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Secondary Antibodies Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Secondary Antibodies Sales Market Share by Region (2015-2020)
2.2.2 Global Secondary Antibodies Revenue Market Share by Region (2015-2020)
2.3 Global Secondary Antibodies Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Secondary Antibodies Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Secondary Antibodies Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Secondary Antibodies Estimates and Projections (2015-2026)
2.4.2 Europe Secondary Antibodies Estimates and Projections (2015-2026)
2.4.3 China Secondary Antibodies Estimates and Projections (2015-2026)
2.4.4 Japan Secondary Antibodies Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Secondary Antibodies Estimates and Projections (2015-2026)
2.4.6 India Secondary Antibodies Estimates and Projections (2015-2026)
3 Global Secondary Antibodies Competition Landscape by Players
3.1 Global Top Secondary Antibodies Players by Sales (2015-2020)
3.2 Global Top Secondary Antibodies Players by Revenue (2015-2020)
3.3 Global Secondary Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Secondary Antibodies as of 2019)
3.4 Global Secondary Antibodies Average Price by Company (2015-2020)
3.5 Manufacturers Secondary Antibodies Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Secondary Antibodies Players (Opinion Leaders)
4 Global Secondary Antibodies Market Size by Type
4.1 Global Secondary Antibodies Historic Market Review by Type (2015-2020)
4.1.1 Global Secondary Antibodies Sales Market Share by Type (2015-2020)
4.1.2 Global Secondary Antibodies Revenue Market Share by Type (2015-2020)
4.1.3 Global Secondary Antibodies Price by Type (2015-2020)
4.2 Global Secondary Antibodies Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Secondary Antibodies Sales Forecast by Type (2021-2026)
4.2.2 Global Secondary Antibodies Revenue Forecast by Type (2021-2026)
4.2.3 Global Secondary Antibodies Price Forecast by Type (2021-2026)
5 Global Secondary Antibodies Market Size by Application
5.1 Global Secondary Antibodies Historic Market Review by Application (2015-2020)
5.1.1 Global Secondary Antibodies Sales Market Share by Application (2015-2020)
5.1.2 Global Secondary Antibodies Revenue Market Share by Application (2015-2020)
5.1.3 Global Secondary Antibodies Price by Application (2015-2020)
5.2 Global Secondary Antibodies Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Secondary Antibodies Sales Forecast by Application (2021-2026)
5.2.2 Global Secondary Antibodies Revenue Forecast by Application (2021-2026)
5.2.3 Global Secondary Antibodies Price Forecast by Application (2021-2026)
6 United States Secondary Antibodies Market Facts & Figures
6.1 United States Secondary Antibodies Sales Market Share by Company (2015-2020)
6.2 United States Secondary Antibodies Sales Market Share by Type (2015-2020)
6.3 United States Secondary Antibodies Sales Market Share by Application (2015-2020)
7 Europe Secondary Antibodies Market Facts & Figures
7.1 Europe Secondary Antibodies Sales Market Share by Company (2015-2020)
7.2 Europe Secondary Antibodies Sales Market Share by Type (2015-2020)
7.3 Europe Secondary Antibodies Sales Market Share by Application (2015-2020)
8 China Secondary Antibodies Market Facts & Figures
8.1 China Secondary Antibodies Sales Market Share by Company (2015-2020)
8.2 China Secondary Antibodies Sales Market Share by Type (2015-2020)
8.3 China Secondary Antibodies Sales Market Share by Application (2015-2020)
9 Japan Secondary Antibodies Market Facts & Figures
9.1 Japan Secondary Antibodies Sales Market Share by Company (3015-3030)
9.2 Japan Secondary Antibodies Sales Market Share by Type (2015-2020)
9.3 Japan Secondary Antibodies Sales Market Share by Application (2015-2020)
10 Southeast Asia Secondary Antibodies Market Facts & Figures
10.1 Southeast Asia Secondary Antibodies Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Secondary Antibodies Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Secondary Antibodies Sales Market Share by Application (2015-2020)
11 India Secondary Antibodies Market Facts & Figures
11.1 India Secondary Antibodies Sales Market Share by Company (2015-2020)
11.2 India Secondary Antibodies Sales Market Share by Type (2015-2020)
11.3 India Secondary Antibodies Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Secondary Antibodies Business
12.1 Thermo Fisher Scientific (US)
12.1.1 Thermo Fisher Scientific (US) Corporation Information
12.1.2 Thermo Fisher Scientific (US) Business Overview
12.1.3 Thermo Fisher Scientific (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Thermo Fisher Scientific (US) Secondary Antibodies Products Offered
12.1.5 Thermo Fisher Scientific (US) Recent Development
12.2 Jackson ImmunoResearch Laboratories (US)
12.2.1 Jackson ImmunoResearch Laboratories (US) Corporation Information
12.2.2 Jackson ImmunoResearch Laboratories (US) Business Overview
12.2.3 Jackson ImmunoResearch Laboratories (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Jackson ImmunoResearch Laboratories (US) Secondary Antibodies Products Offered
12.2.5 Jackson ImmunoResearch Laboratories (US) Recent Development
12.3 BD Biosciences (US)
12.3.1 BD Biosciences (US) Corporation Information
12.3.2 BD Biosciences (US) Business Overview
12.3.3 BD Biosciences (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.3.4 BD Biosciences (US) Secondary Antibodies Products Offered
12.3.5 BD Biosciences (US) Recent Development
12.4 Santa Cruz Biotechnology (US)
12.4.1 Santa Cruz Biotechnology (US) Corporation Information
12.4.2 Santa Cruz Biotechnology (US) Business Overview
12.4.3 Santa Cruz Biotechnology (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Santa Cruz Biotechnology (US) Secondary Antibodies Products Offered
12.4.5 Santa Cruz Biotechnology (US) Recent Development
12.5 GE Healthcare (US)
12.5.1 GE Healthcare (US) Corporation Information
12.5.2 GE Healthcare (US) Business Overview
12.5.3 GE Healthcare (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GE Healthcare (US) Secondary Antibodies Products Offered
12.5.5 GE Healthcare (US) Recent Development
12.6 Sigma-Aldrich (US)
12.6.1 Sigma-Aldrich (US) Corporation Information
12.6.2 Sigma-Aldrich (US) Business Overview
12.6.3 Sigma-Aldrich (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sigma-Aldrich (US) Secondary Antibodies Products Offered
12.6.5 Sigma-Aldrich (US) Recent Development
12.7 Dako (US)
12.7.1 Dako (US) Corporation Information
12.7.2 Dako (US) Business Overview
12.7.3 Dako (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Dako (US) Secondary Antibodies Products Offered
12.7.5 Dako (US) Recent Development
12.8 LI-COR Biosciences (US)
12.8.1 LI-COR Biosciences (US) Corporation Information
12.8.2 LI-COR Biosciences (US) Business Overview
12.8.3 LI-COR Biosciences (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.8.4 LI-COR Biosciences (US) Secondary Antibodies Products Offered
12.8.5 LI-COR Biosciences (US) Recent Development
12.9 SouthernBiotech (US)
12.9.1 SouthernBiotech (US) Corporation Information
12.9.2 SouthernBiotech (US) Business Overview
12.9.3 SouthernBiotech (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.9.4 SouthernBiotech (US) Secondary Antibodies Products Offered
12.9.5 SouthernBiotech (US) Recent Development
12.10 Vector Laboratories (US)
12.10.1 Vector Laboratories (US) Corporation Information
12.10.2 Vector Laboratories (US) Business Overview
12.10.3 Vector Laboratories (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Vector Laboratories (US) Secondary Antibodies Products Offered
12.10.5 Vector Laboratories (US) Recent Development
12.11 Bio-Rad (US)
12.11.1 Bio-Rad (US) Corporation Information
12.11.2 Bio-Rad (US) Business Overview
12.11.3 Bio-Rad (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Bio-Rad (US) Secondary Antibodies Products Offered
12.11.5 Bio-Rad (US) Recent Development
12.12 eBioscience (US)
12.12.1 eBioscience (US) Corporation Information
12.12.2 eBioscience (US) Business Overview
12.12.3 eBioscience (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.12.4 eBioscience (US) Secondary Antibodies Products Offered
12.12.5 eBioscience (US) Recent Development
12.13 Cell Signaling Technology (US)
12.13.1 Cell Signaling Technology (US) Corporation Information
12.13.2 Cell Signaling Technology (US) Business Overview
12.13.3 Cell Signaling Technology (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Cell Signaling Technology (US) Secondary Antibodies Products Offered
12.13.5 Cell Signaling Technology (US) Recent Development
12.14 Dianova (Germany)
12.14.1 Dianova (Germany) Corporation Information
12.14.2 Dianova (Germany) Business Overview
12.14.3 Dianova (Germany) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Dianova (Germany) Secondary Antibodies Products Offered
12.14.5 Dianova (Germany) Recent Development
12.15 Abcam (UK)
12.15.1 Abcam (UK) Corporation Information
12.15.2 Abcam (UK) Business Overview
12.15.3 Abcam (UK) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Abcam (UK) Secondary Antibodies Products Offered
12.15.5 Abcam (UK) Recent Development
12.16 EMD Millipore (US)
12.16.1 EMD Millipore (US) Corporation Information
12.16.2 EMD Millipore (US) Business Overview
12.16.3 EMD Millipore (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.16.4 EMD Millipore (US) Secondary Antibodies Products Offered
12.16.5 EMD Millipore (US) Recent Development
12.17 R&D Systems (US)
12.17.1 R&D Systems (US) Corporation Information
12.17.2 R&D Systems (US) Business Overview
12.17.3 R&D Systems (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.17.4 R&D Systems (US) Secondary Antibodies Products Offered
12.17.5 R&D Systems (US) Recent Development
12.18 Rockland Immunochemicals (US)
12.18.1 Rockland Immunochemicals (US) Corporation Information
12.18.2 Rockland Immunochemicals (US) Business Overview
12.18.3 Rockland Immunochemicals (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Rockland Immunochemicals (US) Secondary Antibodies Products Offered
12.18.5 Rockland Immunochemicals (US) Recent Development
12.19 Bethyl (US)
12.19.1 Bethyl (US) Corporation Information
12.19.2 Bethyl (US) Business Overview
12.19.3 Bethyl (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Bethyl (US) Secondary Antibodies Products Offered
12.19.5 Bethyl (US) Recent Development
12.20 Kirkegaard & Perry Laboratories (US)
12.20.1 Kirkegaard & Perry Laboratories (US) Corporation Information
12.20.2 Kirkegaard & Perry Laboratories (US) Business Overview
12.20.3 Kirkegaard & Perry Laboratories (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Kirkegaard & Perry Laboratories (US) Secondary Antibodies Products Offered
12.20.5 Kirkegaard & Perry Laboratories (US) Recent Development
12.21 BioLegend (US)
12.21.1 BioLegend (US) Corporation Information
12.21.2 BioLegend (US) Business Overview
12.21.3 BioLegend (US) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.21.4 BioLegend (US) Secondary Antibodies Products Offered
12.21.5 BioLegend (US) Recent Development
12.22 Abbexa (UK)
12.22.1 Abbexa (UK) Corporation Information
12.22.2 Abbexa (UK) Business Overview
12.22.3 Abbexa (UK) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Abbexa (UK) Secondary Antibodies Products Offered
12.22.5 Abbexa (UK) Recent Development
12.23 Biorbyt (UK)
12.23.1 Biorbyt (UK) Corporation Information
12.23.2 Biorbyt (UK) Business Overview
12.23.3 Biorbyt (UK) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.23.4 Biorbyt (UK) Secondary Antibodies Products Offered
12.23.5 Biorbyt (UK) Recent Development
12.24 Acris Antibodies (Germany)
12.24.1 Acris Antibodies (Germany) Corporation Information
12.24.2 Acris Antibodies (Germany) Business Overview
12.24.3 Acris Antibodies (Germany) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.24.4 Acris Antibodies (Germany) Secondary Antibodies Products Offered
12.24.5 Acris Antibodies (Germany) Recent Development
12.25 BioLogo (Germany)
12.25.1 BioLogo (Germany) Corporation Information
12.25.2 BioLogo (Germany) Business Overview
12.25.3 BioLogo (Germany) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.25.4 BioLogo (Germany) Secondary Antibodies Products Offered
12.25.5 BioLogo (Germany) Recent Development
12.26 Sino Biological (China)
12.26.1 Sino Biological (China) Corporation Information
12.26.2 Sino Biological (China) Business Overview
12.26.3 Sino Biological (China) Secondary Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.26.4 Sino Biological (China) Secondary Antibodies Products Offered
12.26.5 Sino Biological (China) Recent Development
13 Secondary Antibodies Manufacturing Cost Analysis
13.1 Secondary Antibodies Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Secondary Antibodies
13.4 Secondary Antibodies Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Secondary Antibodies Distributors List
14.3 Secondary Antibodies Customers
15 Market Dynamics
15.1 Secondary Antibodies Market Trends
15.2 Secondary Antibodies Opportunities and Drivers
15.3 Secondary Antibodies Market Challenges
15.4 Secondary Antibodies Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Secondary Antibodies Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Secondary Antibodies Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Secondary Antibodies Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Secondary Antibodies Sales (MT) by Region (2015-2020)
Table 5. Global Secondary Antibodies Sales Market Share by Region (2015-2020)
Table 6. Global Secondary Antibodies Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Secondary Antibodies Revenue Share by Region (2015-2020)
Table 8. Global Secondary Antibodies Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Secondary Antibodies Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Secondary Antibodies Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Secondary Antibodies Revenue Share Forecast by Region (2021-2026)
Table 12. Global Secondary Antibodies (MT) of Key Companies (2015-2020)
Table 13. Global Secondary Antibodies Sales Share by Company (2015-2020)
Table 14. Global Secondary Antibodies Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Secondary Antibodies Revenue Share by Company (2015-2020)
Table 16. Global Secondary Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Secondary Antibodies as of 2019)
Table 17. Global Secondary Antibodies Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Secondary Antibodies Manufacturing Sites and Area Served
Table 19. Manufacturers Secondary Antibodies Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Secondary Antibodies Players
Table 22. Global Secondary Antibodies Sales (MT) by Type (2015-2020)
Table 23. Global Secondary Antibodies Sales Share by Type (2015-2020)
Table 24. Global Secondary Antibodies Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Secondary Antibodies Price (MT) by Type (2015-2020)
Table 26. Global Secondary Antibodies Sales Share by Type (2021-2026)
Table 27. Global Secondary Antibodies Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Secondary Antibodies Revenue Share by Type (2021-2026)
Table 29. Global Secondary Antibodies Price (MT) by Type (2021-2026)
Table 30. Global Secondary Antibodies Sales (MT) by Application (2015-2020)
Table 31. Global Secondary Antibodies Sales Share by Application (2015-2020)
Table 32. Global Secondary Antibodies Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Secondary Antibodies Price (MT) by Application (2015-2020)
Table 34. Global Secondary Antibodies Sales (MT) by Application (2021-2026)
Table 35. Global Secondary Antibodies Sales Share by Application (2021-2026)
Table 36. Global Secondary Antibodies Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Secondary Antibodies Revenue Share by Application (2021-2026)
Table 38. Global Secondary Antibodies Price (MT) by Application (2021-2026)
Table 39. United States Secondary Antibodies Sales (MT) by Company (2015-2020)
Table 40. United States Secondary Antibodies Sales Market Share by Company (2015-2020)
Table 41. United States Secondary Antibodies Sales (MT) by Type (2015-2020)
Table 42. United States Secondary Antibodies Sales Market Share by Type (2015-2020)
Table 43. United States Secondary Antibodies Sales (MT) by Application (2015-2020)
Table 44. United States Secondary Antibodies Sales Market Share by Application (2015-2020)
Table 45. Europe Secondary Antibodies Sales (MT) by Company (2015-2020)
Table 46. Europe Secondary Antibodies Sales Market Share by Company (2015-2020)
Table 47. Europe Secondary Antibodies Sales (MT) by Type (2015-2020)
Table 48. Europe Secondary Antibodies Sales Market Share by Type (2015-2020)
Table 49. Europe Secondary Antibodies Sales (MT) by Application (2015-2020)
Table 50. Europe Secondary Antibodies Sales Market Share by Type (2015-2020)
Table 51. China Secondary Antibodies Sales (MT) by Company (2015-2020)
Table 52. China Secondary Antibodies Sales Market Share by Company (2015-2020)
Table 53. China Secondary Antibodies Sales (MT) by Type (2015-2020)
Table 54. China Secondary Antibodies Sales Market Share by Type (2015-2020)
Table 55. China Secondary Antibodies Sales (MT) by Application (2015-2020)
Table 56. China Secondary Antibodies Sales Market Share by Application (2015-2020)
Table 57. Japan Secondary Antibodies Sales (MT) by Company (2015-2020)
Table 58. Japan Secondary Antibodies Sales Market Share by Company (2015-2020)
Table 59. Japan Secondary Antibodies Sales (MT) by Type (2015-2020)
Table 60. Japan Secondary Antibodies Sales Market Share by Type (2015-2020)
Table 61. Japan Secondary Antibodies Sales (MT) by Application (2015-2020)
Table 62. Japan Secondary Antibodies Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Secondary Antibodies Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Secondary Antibodies Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Secondary Antibodies Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Secondary Antibodies Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Secondary Antibodies Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Secondary Antibodies Sales Market Share by Application (2015-2020)
Table 69. India Secondary Antibodies Sales (MT) by Company (2015-2020)
Table 70. India Secondary Antibodies Sales Market Share by Company (2015-2020)
Table 71. India Secondary Antibodies Sales (MT) by Type (2015-2020)
Table 72. India Secondary Antibodies Sales Market Share by Type (2015-2020)
Table 73. India Secondary Antibodies Sales (MT) by Application (2015-2020)
Table 74. India Secondary Antibodies Sales Market Share by Application (2015-2020)
Table 75. Thermo Fisher Scientific (US) Corporation Information
Table 76. Thermo Fisher Scientific (US) Description and Business Overview
Table 77. Thermo Fisher Scientific (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Thermo Fisher Scientific (US) Secondary Antibodies Product
Table 79. Thermo Fisher Scientific (US) Recent Development
Table 80. Jackson ImmunoResearch Laboratories (US) Corporation Information
Table 81. Jackson ImmunoResearch Laboratories (US) Description and Business Overview
Table 82. Jackson ImmunoResearch Laboratories (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Jackson ImmunoResearch Laboratories (US) Secondary Antibodies Product
Table 84. Jackson ImmunoResearch Laboratories (US) Recent Development
Table 85. BD Biosciences (US) Corporation Information
Table 86. BD Biosciences (US) Description and Business Overview
Table 87. BD Biosciences (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. BD Biosciences (US) Secondary Antibodies Product
Table 89. BD Biosciences (US) Recent Development
Table 90. Santa Cruz Biotechnology (US) Corporation Information
Table 91. Santa Cruz Biotechnology (US) Description and Business Overview
Table 92. Santa Cruz Biotechnology (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Santa Cruz Biotechnology (US) Secondary Antibodies Product
Table 94. Santa Cruz Biotechnology (US) Recent Development
Table 95. GE Healthcare (US) Corporation Information
Table 96. GE Healthcare (US) Description and Business Overview
Table 97. GE Healthcare (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. GE Healthcare (US) Secondary Antibodies Product
Table 99. GE Healthcare (US) Recent Development
Table 100. Sigma-Aldrich (US) Corporation Information
Table 101. Sigma-Aldrich (US) Description and Business Overview
Table 102. Sigma-Aldrich (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Sigma-Aldrich (US) Secondary Antibodies Product
Table 104. Sigma-Aldrich (US) Recent Development
Table 105. Dako (US) Corporation Information
Table 106. Dako (US) Description and Business Overview
Table 107. Dako (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Dako (US) Secondary Antibodies Product
Table 109. Dako (US) Recent Development
Table 110. LI-COR Biosciences (US) Corporation Information
Table 111. LI-COR Biosciences (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. LI-COR Biosciences (US) Description and Business Overview
Table 113. LI-COR Biosciences (US) Secondary Antibodies Product
Table 114. LI-COR Biosciences (US) Recent Development
Table 115. SouthernBiotech (US) Corporation Information
Table 116. SouthernBiotech (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. SouthernBiotech (US) Description and Business Overview
Table 118. SouthernBiotech (US) Secondary Antibodies Product
Table 119. SouthernBiotech (US) Recent Development
Table 120. Vector Laboratories (US) Corporation Information
Table 121. Vector Laboratories (US) Description and Business Overview
Table 122. Vector Laboratories (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Vector Laboratories (US) Secondary Antibodies Product
Table 124. Vector Laboratories (US) Recent Development
Table 125. Bio-Rad (US) Corporation Information
Table 126. Bio-Rad (US) Description and Business Overview
Table 127. Bio-Rad (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Bio-Rad (US) Secondary Antibodies Product
Table 129. Bio-Rad (US) Recent Development
Table 130. eBioscience (US) Corporation Information
Table 131. eBioscience (US) Description and Business Overview
Table 132. eBioscience (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. eBioscience (US) Secondary Antibodies Product
Table 134. eBioscience (US) Recent Development
Table 135. Cell Signaling Technology (US) Corporation Information
Table 136. Cell Signaling Technology (US) Description and Business Overview
Table 137. Cell Signaling Technology (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Cell Signaling Technology (US) Secondary Antibodies Product
Table 139. Cell Signaling Technology (US) Recent Development
Table 140. Dianova (Germany) Corporation Information
Table 141. Dianova (Germany) Description and Business Overview
Table 142. Dianova (Germany) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Dianova (Germany) Secondary Antibodies Product
Table 144. Dianova (Germany) Recent Development
Table 145. Abcam (UK) Corporation Information
Table 146. Abcam (UK) Description and Business Overview
Table 147. Abcam (UK) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Abcam (UK) Secondary Antibodies Product
Table 149. Abcam (UK) Recent Development
Table 150. EMD Millipore (US) Corporation Information
Table 151. EMD Millipore (US) Description and Business Overview
Table 152. EMD Millipore (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. EMD Millipore (US) Secondary Antibodies Product
Table 154. EMD Millipore (US) Recent Development
Table 155. R&D Systems (US) Corporation Information
Table 156. R&D Systems (US) Description and Business Overview
Table 157. R&D Systems (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. R&D Systems (US) Secondary Antibodies Product
Table 159. R&D Systems (US) Recent Development
Table 160. Rockland Immunochemicals (US) Corporation Information
Table 161. Rockland Immunochemicals (US) Description and Business Overview
Table 162. Rockland Immunochemicals (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. Rockland Immunochemicals (US) Secondary Antibodies Product
Table 164. Rockland Immunochemicals (US) Recent Development
Table 165. Bethyl (US) Corporation Information
Table 166. Bethyl (US) Description and Business Overview
Table 167. Bethyl (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Bethyl (US) Secondary Antibodies Product
Table 169. Bethyl (US) Recent Development
Table 170. Kirkegaard & Perry Laboratories (US) Corporation Information
Table 171. Kirkegaard & Perry Laboratories (US) Description and Business Overview
Table 172. Kirkegaard & Perry Laboratories (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 173. Kirkegaard & Perry Laboratories (US) Secondary Antibodies Product
Table 174. Kirkegaard & Perry Laboratories (US) Recent Development
Table 175. BioLegend (US) Corporation Information
Table 176. BioLegend (US) Description and Business Overview
Table 177. BioLegend (US) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 178. BioLegend (US) Secondary Antibodies Product
Table 179. BioLegend (US) Recent Development
Table 180. Abbexa (UK) Corporation Information
Table 181. Abbexa (UK) Description and Business Overview
Table 182. Abbexa (UK) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 183. Abbexa (UK) Secondary Antibodies Product
Table 184. Abbexa (UK) Recent Development
Table 185. Biorbyt (UK) Corporation Information
Table 186. Biorbyt (UK) Description and Business Overview
Table 187. Biorbyt (UK) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 188. Biorbyt (UK) Secondary Antibodies Product
Table 189. Biorbyt (UK) Recent Development
Table 190. Acris Antibodies (Germany) Corporation Information
Table 191. Acris Antibodies (Germany) Description and Business Overview
Table 192. Acris Antibodies (Germany) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 193. Acris Antibodies (Germany) Secondary Antibodies Product
Table 194. Acris Antibodies (Germany) Recent Development
Table 195. BioLogo (Germany) Corporation Information
Table 196. BioLogo (Germany) Description and Business Overview
Table 197. BioLogo (Germany) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 198. BioLogo (Germany) Secondary Antibodies Product
Table 199. BioLogo (Germany) Recent Development
Table 200. Sino Biological (China) Corporation Information
Table 201. Sino Biological (China) Description and Business Overview
Table 202. Sino Biological (China) Secondary Antibodies Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 203. Sino Biological (China) Secondary Antibodies Product
Table 204. Sino Biological (China) Recent Development
Table 205. Production Base and Market Concentration Rate of Raw Material
Table 206. Key Suppliers of Raw Materials
Table 207. Secondary Antibodies Distributors List
Table 208. Secondary Antibodies Customers List
Table 209. Secondary Antibodies Market Key Trends
Table 210. Secondary Antibodies Key Opportunities and Drivers
Table 211. Secondary Antibodies Market Challenges
Table 212. Research Programs/Design for This Report
Table 213. Key Data Information from Secondary Sources
Table 214. Key Data Information from Primary Sources
List of Figures
Figure 1. Secondary Antibodies Product Picture
Figure 2. Global Secondary Antibodies Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Secondary Antibodies Market Share by Application in 2020 & 2026
Figure 6. ELISA (Including Many HIV Tests) Examples
Figure 7. Western Blot Examples
Figure 8. Immunostaining Examples
Figure 9. Immunohistochemistry Examples
Figure 10. Immunocytochemistry Examples
Figure 11. Global Secondary Antibodies Sales (MT) Growth Rate (2015-2026)
Figure 12. Global Secondary Antibodies Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Secondary Antibodies Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 14. Global Secondary Antibodies Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Secondary Antibodies Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Secondary Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Secondary Antibodies Sales (MT) Growth Rate (2015-2026)
Figure 18. Europe Secondary Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Secondary Antibodies Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Secondary Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Secondary Antibodies Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Secondary Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Secondary Antibodies Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Secondary Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Secondary Antibodies Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Secondary Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Secondary Antibodies Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Secondary Antibodies Players Market Share by Revenue in Secondary Antibodies 2015 & 2019
Figure 29. Secondary Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Secondary Antibodies Revenue Share by Type (2015-2020)
Figure 31. Global Secondary Antibodies Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Secondary Antibodies Revenue Share by Application (2015-2020)
Figure 33. Global Secondary Antibodies Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Secondary Antibodies Sales Market Share by Type in 2019
Figure 35. United States Secondary Antibodies Sales Market Share by Type in 2019
Figure 36. Europe Secondary Antibodies Sales Market Share by Company in 2019
Figure 37. Europe Secondary Antibodies Sales Market Share by Type in 2019
Figure 38. Europe Secondary Antibodies Sales Market Share by Application in 2019
Figure 39. China Secondary Antibodies Sales Market Share by Company in 2019
Figure 40. China Secondary Antibodies Sales Market Share by Type in 2019
Figure 41. China Secondary Antibodies Sales Market Share by Application in 2019
Figure 42. Japan Secondary Antibodies Sales Market Share by Company in 2019
Figure 43. Japan Secondary Antibodies Sales Market Share by Type in 2019
Figure 44. Japan Secondary Antibodies Sales Market Share by Application in 2019
Figure 45. Southeast Asia Secondary Antibodies Sales Market Share by Company in 2019
Figure 46. Southeast Asia Secondary Antibodies Sales Market Share by Type in 2019
Figure 47. Southeast Asia Secondary Antibodies Sales Market Share by Application in 2019
Figure 48. India Secondary Antibodies Sales Market Share by Company in 2019
Figure 49. India Secondary Antibodies Sales Market Share by Type in 2019
Figure 50. India Secondary Antibodies Sales Market Share by Application in 2019
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Secondary Antibodies
Figure 53. Manufacturing Process Analysis of Secondary Antibodies
Figure 54. Secondary Antibodies Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Porter's Five Forces Analysis
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
バイオシミラーモノクローナル抗体の世界市場レポート2020 Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are calle…- 抗体＆試薬研究の世界市場レポート2020 Market Analysis and Insights: Global Research Antibodies and Reagents Market The global Research Antibodies and Reagents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Research Antibodies and Reagents Scope and Market …
- 二重バレル抗体薬の世界市場レポート2020 Market Analysis and Insights: Global Double Barreled Antibodies Drug Market The global Double Barreled Antibodies Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Double Barreled Antibodies Drug Scope and Market Siz…
- 二次性副甲状腺機能亢進症薬の世界市場レポート2020 Market Analysis and Insights: Global Secondary Hyperparathyroidism Drug Market The global Secondary Hyperparathyroidism Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Secondary Hyperparathyroidism Drug Scope and M…
- リチウム金属二次電池の世界市場レポート2020 A lithium-metal secondary battery refers to a secondary battery using lithium metal or lithium alloy as a negative electrode. Lithium metal has a low density of 0.54 g/cm3 and a significantly low standard reduction potential of −3.045 V (SHE: based on the standard hydrogen electrode), and thus has b…